PEREGRINE CAPITAL MANAGEMENT LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q4 2021$5,994,000
-12.1%
125,653
+22.4%
0.12%
-14.9%
Q3 2021$6,819,000
-28.9%
102,652
-16.5%
0.14%
-18.0%
Q2 2021$9,595,000
+4.6%
122,983
+26.8%
0.17%
+1.2%
Q1 2021$9,177,000
-31.9%
97,015
-12.3%
0.17%
-33.6%
Q4 2020$13,475,000
+55.8%
110,585
+11.7%
0.26%
+11.8%
Q3 2020$8,649,00099,0010.23%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q4 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders